OMEGAVEN Israel - English - Ministry of Health

omegaven

cure medical & technical supply - glycerol; highly refined fish oil; purified egg phosphatide - emulsion for infusion - glycerol 2.5 g / 100 ml; purified egg phosphatide 1.2 g / 100 ml; highly refined fish oil 10 g / 100 ml - fat emulsions - fat emulsions - parenteral nutrition supplementation with long chain omega-3-fatty acids, especially eicosapentaenoic and docosahexaenoic acids when oral or enternal nutrition is impossible, insufficient or contraindicated.

OMEGAVEN Israel - English - Ministry of Health

omegaven

cure medical & technical supply - glycerol; highly refined fish oil; purified egg phosphatide - emulsion for infusion - glycerol 2.5 g / 100 ml; purified egg phosphatide 1.2 g / 100 ml; highly refined fish oil 10 g / 100 ml - fat emulsions - parenteral nutrition supplementation with long chain omega-3-fatty acids, especially eicosapentaenoic and docosahexaenoic acids when oral or enternal nutrition is impossible, insufficient or contraindicated.

OMEGAVEN Israel - English - Ministry of Health

omegaven

cure medical & technical supply - glycerol; highly refined fish oil; purified egg phosphatide - emulsion for infusion - glycerol 2.5 g / 100 ml; purified egg phosphatide 1.2 g / 100 ml; highly refined fish oil 10 g / 100 ml - fat emulsions - parenteral nutrition supplementation with long chain omega-3-fatty acids, especially eicosapentaenoic and docosahexaenoic acids when oral or enternal nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN ELECTROLYTE FREE amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 2463 mL Australia - English - Department of Health (Therapeutic Goods Administration)

smofkabiven electrolyte free amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 2463 ml

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: egg lecithin; glycerol; sodium oleate; water for injections; sodium hydroxide; dl-alpha-tocopherol - parenteral nutrition for adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1970 mL Australia - English - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1970 ml

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; soya oil, quantity: 60 g/l; olive oil, quantity: 50 g/l; medium chain triglycerides, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; sodium oleate; egg lecithin; glycerol; water for injections; dl-alpha-tocopherol - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN ELECTROLYTE FREE amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 1970 mL Australia - English - Department of Health (Therapeutic Goods Administration)

smofkabiven electrolyte free amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 1970 ml

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; soya oil, quantity: 60 g/l; olive oil, quantity: 50 g/l; medium chain triglycerides, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: sodium oleate; water for injections; egg lecithin; dl-alpha-tocopherol; sodium hydroxide; glycerol - parenteral nutrition for adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1477 mL Australia - English - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1477 ml

fresenius kabi australia pty ltd - olive oil, quantity: 50 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: water for injections; dl-alpha-tocopherol; sodium oleate; sodium hydroxide; egg lecithin; glycerol - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN ELECTROLYTE FREE amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 986 mL Australia - English - Department of Health (Therapeutic Goods Administration)

smofkabiven electrolyte free amino acids 5.1% / lipids 3.8% / glucose 12.7% emulsion for intravenous infusion bag 986 ml

fresenius kabi australia pty ltd - medium chain triglycerides, quantity: 60 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; water for injections; sodium hydroxide; egg lecithin; glycerol; sodium oleate - parenteral nutrition for adult patients when oral or enteral nutrition is impossible, insufficient or contraindicated.

Omegaven New Zealand - English - Medsafe (Medicines Safety Authority)

omegaven

fresenius kabi new zealand limited - egg lecithin 1.2%{relative} (as a component in fish oil);  ; fish oil 10%{relative} (highly refined); glycerol 2.5%{relative} (as a component in fish oil) - emulsion for infusion - active: egg lecithin 1.2%{relative} (as a component in fish oil)   fish oil 10%{relative} (highly refined) glycerol 2.5%{relative} (as a component in fish oil) excipient: sodium hydroxide sodium oleate water for injection - for use as a fraction of the lipid emulsion component for total parenteral nutrition, providing supplements of long chain omega-3-fatty acids especially eicosapentanoic and docosahexanoic acid when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFlipid New Zealand - English - Medsafe (Medicines Safety Authority)

smoflipid

fresenius kabi new zealand limited - fish oil 30 g; medium-chain triglycerides 60 g;  ; olive oil 50 g;  ; soya oil 60 g;   - emulsion for infusion - 20 % - active: fish oil 30 g medium-chain triglycerides 60 g   olive oil 50 g   soya oil 60 g   excipient: dl-alpha tocopherol egg lecithin glycerol sodium hydroxide sodium oleate water for injection - supply of energy and essential fatty acids to patients, as part of a parenteral nutrition regimen, when oral or enteral nutrition is impossible, insufficient or contraindicated.